300642 Stock Overview
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Tellgen Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.55 |
| 52 Week High | CN¥22.81 |
| 52 Week Low | CN¥9.94 |
| Beta | 0.39 |
| 1 Month Change | -14.63% |
| 3 Month Change | -20.42% |
| 1 Year Change | -44.69% |
| 3 Year Change | -60.92% |
| 5 Year Change | -45.24% |
| Change since IPO | -34.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300642 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -8.2% | -1.6% | -0.4% |
| 1Y | -44.7% | -21.5% | -16.2% |
Return vs Industry: 300642 underperformed the CN Medical Equipment industry which returned -21.7% over the past year.
Return vs Market: 300642 underperformed the CN Market which returned -17.6% over the past year.
Price Volatility
| 300642 volatility | |
|---|---|
| 300642 Average Weekly Movement | 9.4% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 300642's share price has been volatile over the past 3 months.
Volatility Over Time: 300642's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 710 | Jian Er Yao | www.tellgen.com |
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; cardiovascular and inflammation; biochemistry kits; DNA methylation testing kits; and molecular detection of COVID-19 and others. It also provides diagnostic reagents/testing instruments and assembly lines.
Tellgen Corporation Fundamentals Summary
| 300642 fundamental statistics | |
|---|---|
| Market cap | CN¥2.05b |
| Earnings (TTM) | CN¥116.51m |
| Revenue (TTM) | CN¥671.35m |
17.6x
P/E Ratio3.0x
P/S RatioIs 300642 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300642 income statement (TTM) | |
|---|---|
| Revenue | CN¥671.35m |
| Cost of Revenue | CN¥262.41m |
| Gross Profit | CN¥408.94m |
| Other Expenses | CN¥292.44m |
| Earnings | CN¥116.51m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Apr 23, 2024
| Earnings per share (EPS) | 0.71 |
| Gross Margin | 60.91% |
| Net Profit Margin | 17.35% |
| Debt/Equity Ratio | 0.7% |
How did 300642 perform over the long term?
See historical performance and comparison